Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novogen Ltd (NASDAQ:NVGN)

2.40
Delayed Data
As of 2:27pm ET
 -0.0053 / -0.22%
Today’s Change
1.51
Today|||52-Week Range
9.50
+15.38%
Year-to-Date

Today’s Trading

Previous close2.41
Today’s open2.42
Day’s range2.38 - 2.58
Volume137,849
Average volume (3 months)201,073
Market cap$16.2M
Dividend yield--
Data as of 2:27pm ET, 09/03/2015

Growth & Valuation

Earnings growth (last year)+18.03%
Earnings growth (this year)--
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book13.39

Competitors

 Today’s
change
Today’s
% change
ECTEEcho Therapeutics In...+0.10+6.80%
CDXICardax Inc0.000.00%
DARADARA BioSciences Inc-0.02-1.89%
CAPNCapnia Inc+0.08+3.62%
Data as of 3:03pm ET, 09/03/2015

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$0.00
Annual profit (last year)-$6.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Iain Gladstone Ross
COO, Head-Administration &
Finance
Cristyn Humphreys
Corporate headquarters
Hornsby, New South Wales (nsw)

Forecasts

Partner Offers